Dr Robin Carhart-Harris
Head of Centre for Psychedelic Research, Imperial College London
Dr Robin Carhart-Harris has worked extensively within the field of psychedelic research and is part of the team at Imperial College London conducting pioneering clinical trials.
Dr Carhart-Harris moved to Imperial College London in 2008 after obtaining a PhD in Psychopharmacology from the University of Bristol and an MA in Psychoanalysis from Brunel University.
At Imperial, Robin has designed and completed human brain imaging studies with LSD, psilocybin, MDMA and DMT, a clinical trial of psilocybin for treatment-resistant depression, a double-blind randomised controlled trial comparing psilocybin with escitalopram for major depressive disorder and a multimodal imaging study in healthy volunteers receiving psilocybin for the first time.
Robin founded the Centre for Psychedelic Research at Imperial College London in April 2019, the first of its kind in the world.
He is an experienced speaker with the skills to inspire the audience to learn more about this fascinating topic. Through his role, Dr Carhart-Harris has knowledge of the interaction between science, politics and public policy.